 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 November 2003 | Volume 139 Issue 10 | Pages 802-809
Background: Insulin resistance is more common in overweight individuals and is associated with increased risk for type 2 diabetes mellitus and cardiovascular disease. Given the current epidemic of obesity and the fact that lifestyle interventions, such as weight loss and exercise, decrease insulin resistance, a relatively simple means to identify overweight individuals who are insulin resistant would be clinically useful.
Objective: To evaluate the ability of metabolic markers associated with insulin resistance and increased risk for cardiovascular disease to identify the subset of overweight individuals who are insulin resistant.
Design: Cross-sectional study.
Setting: General clinical research center.
Patients: 258 nondiabetic, overweight volunteers.
Measurements: Body mass index; fasting glucose, insulin, lipid and lipoprotein concentrations; and insulin-mediated glucose disposal as quantified by the steady-state plasma glucose concentration during the insulin suppression test. Overweight was defined as body mass index of 25 kg/m2 or greater, and insulin resistance was defined as being in the top tertile of steady-state plasma glucose concentrations. Receiver-operating characteristic curve analysis was used to identify the best markers of insulin resistance; optimal cut-points were identified and analyzed for predictive power.
Results: Plasma triglyceride concentration, ratio of triglyceride to high-density lipoprotein cholesterol concentrations, and insulin concentration were the most useful metabolic markers in identifying insulin-resistant individuals. The optimal cut-points were 1.47 mmol/L (130 mg/dL) for triglyceride, 1.8 in SI units (3.0 in traditional units) for the triglyceride–high-density lipoprotein cholesterol ratio, and 109 pmol/L for insulin. Respective sensitivity and specifity for these cut-points were 67%, 64%, and 57% and 71%, 68%, and 85%. Their ability to identify insulin-resistant individuals was similar to the ability of the criteria proposed by the Adult Treatment Panel III to diagnose the metabolic syndrome (sensitivity, 52%, and specificity, 85%).
Conclusions: Three relatively simple metabolic markers can help identify overweight individuals who are sufficiently insulin resistant to be at increased risk for various adverse outcomes. In the absence of a standardized insulin assay, we suggest that the most practical approach to identify overweight individuals who are insulin resistant is to use the cut-points for either triglyceride concentration or the triglyceride–high-density lipoprotein cholesterol concentration ratio.
Editors' Notes
Context
Contribution
Implications
–The Editors
Author and Article Information
From Stanford University School of Medicine, Stanford, California.
Grant Support: By National Institutes of Health grants RR000070-40 and RR16071-01.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Gerald Reaven, MD, Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305.
Current Author Addresses: Drs. McLaughlin and Chu: Division of Endocrinology, Stanford University School of Medicine, Room S005, Stanford, CA 94305-5103.
Drs. Reaven, Abbasi, and Ms. Lamendola: Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305.
Ms. Cheal: Department of Psychiatry, Brigham and Women's Hospital, 350 Longwood Avenue, Suite 201, Boston, MA 02115.
Author Contributions: Conception and design: T. McLaughlin, K. Cheal, J. Chu, G. Reaven.
Analysis and interpretation of the data: T. McLaughlin, G. Reaven.
Drafting of the article: T. McLaughlin, G. Reaven.
Critical revision of the article for important intellectual content: T. McLaughlin, G. Reaven.
Final approval of the article: T. McLaughlin, G. Reaven.
Provision of study materials or patients: T. McLaughlin, F. Abbasi, C. Lamendola, G. Reaven.
Statistical expertise: T. McLaughlin, K. Cheal, G. Reaven.
Obtaining of funding: T. McLaughlin, G. Reaven.
Administrative, technical, or logistic support: T. McLaughlin, F. Abbasi, C. Lamendola.
Collection and assembly of data: T. McLaughlin, F. Abbasi. ARTICLE
Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D. S.H. Bell and J. H. O'Keefe Letter by Bell and O'Keefe Regarding Article, "Use of Alternative Thresholds Defining Insulin Resistance to Predict Incident Type 2 Diabetes Mellitus and Cardiovascular Disease" Circulation, September 9, 2008; 118(11): e156 - e156. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, and H.-U. Haring Identification and Characterization of Metabolically Benign Obesity in Humans Arch Intern Med, August 11, 2008; 168(15): 1609 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Polak, Z Kovacova, C Holst, C Verdich, A Astrup, E Blaak, K Patel, J M Oppert, D Langin, J A Martinez, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol., April 1, 2008; 158(4): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Porrini, P. Delgado, A. Alvarez, M. Cobo, L. Perez, J. M. Gonzalez-Posada, L. Hortal, R. Gallego, J. J. Garcia, M. Checa, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Jacobs, M. E. Martinez, D. S. Alberts, E. L. Ashbeck, S. M. Gapstur, P. Lance, and P. A. Thompson Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 300 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Riserus, J. Arnlov, and L. Berglund Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men Diabetes Care, November 1, 2007; 30(11): 2928 - 2933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Boyko and C. C. Jensen Do We Know What Homeostasis Model Assessment Measures?: If not, does it matter? Diabetes Care, October 1, 2007; 30(10): 2725 - 2728. [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Lien, A. J. Brown, J. D. Ard, C. Loria, T. P. Erlinger, A. C. Feldstein, P.-H. Lin, C. M. Champagne, A. C. King, H. L. McGuire, et al. Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome Hypertension, October 1, 2007; 50(4): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Sung, M. C. Ryan, B. S. Kim, Y. K. Cho, B. I. Kim, and G. M. Reaven Relationships Between Estimates of Adiposity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in a Large Group of Nondiabetic Korean Adults Diabetes Care, August 1, 2007; 30(8): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, L. E. Wagenknecht, A. Festa, R. B. D'Agostino Jr., and S. M. Haffner Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care, July 1, 2007; 30(7): 1819 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reaven The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? J. Am. Coll. Nutr., June 1, 2007; 26(3): 191 - 195. [Full Text] [PDF]
|
|
|
|
|
|
C. Beysen, E. J. Murphy, T. McLaughlin, T. Riiff, C. Lamendola, H. C. Turner, M. Awada, S. M. Turner, G. Reaven, and M. K. Hellerstein Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo Diabetes Care, May 1, 2007; 30(5): 1143 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Ryan, F. Abbasi, C. Lamendola, S. Carter, and T. L. McLaughlin Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults Diabetes Care, May 1, 2007; 30(5): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Barzilay, C. Blaum, T. Moore, Q. Li Xue, C. H. Hirsch, J. D. Walston, and L. P. Fried Insulin Resistance and Inflammation as Precursors of Frailty: The Cardiovascular Health Study Arch Intern Med, April 9, 2007; 167(7): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. McLaughlin, F. Abbasi, C. Lamendola, and G. Reaven Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity Arch Intern Med, April 9, 2007; 167(7): 642 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn Metabolic Syndrome: Is It a Syndrome? Does It Matter? Circulation, April 3, 2007; 115(13): 1806 - 1811. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF]
|
|
|
|
|
|
C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Simo, A. Lecube, J. Genesca, J. I. Esteban, and C. Hernandez Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection. Diabetes Care, November 1, 2006; 29(11): 2462 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.D.H. Malnick and H. Knobler The medical complications of obesity QJM, September 1, 2006; 99(9): 565 - 579. [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Kim, L. Chunawala, R. Linde, and G. M. Reaven Comparison of the 1997 and 2003 American Diabetes Association Classification of Impaired Fasting Glucose: Impact on Prevalence of Impaired Fasting Glucose, Coronary Heart Disease Risk Factors, and Coronary Heart Disease in a Community-Based Medical Practice J. Am. Coll. Cardiol., July 18, 2006; 48(2): 293 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn The Metabolic Syndrome (Emperor) Wears No Clothes Diabetes Care, July 1, 2006; 29(7): 1693 - 1696. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Third Annual World Congress on the Insulin Resistance Syndrome: Mediators, antecedents, and measurement Diabetes Care, July 1, 2006; 29(7): 1700 - 1706. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ovbiagele, J. L. Saver, M. J. Lynn, M. Chimowitz, and for the WASID Study Group Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis Neurology, May 9, 2006; 66(9): 1344 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davidson, J. K. Hix, D. G. Vidt, and D. J. Brotman Association of Impaired Diurnal Blood Pressure Variation With a Subsequent Decline in Glomerular Filtration Rate. Arch Intern Med, April 24, 2006; 166(8): 846 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cordero and E Alegria Sex differences and cardiovascular risk Heart, February 1, 2006; 92(2): 145 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Reaven and T. McLaughlin Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans Arch Intern Med, January 23, 2006; 166(2): 249 - 249. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Sumner Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans--Reply Arch Intern Med, January 23, 2006; 166(2): 249 - 250. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Farin, F. Abbasi, and G. M Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pladevall, B. Singal, L. K. Williams, C. Brotons, H. Guyer, J. Sadurni, C. Falces, M. Serrano-Rios, R. Gabriel, J. E. Shaw, et al. A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysis Diabetes Care, January 1, 2006; 29(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Zachary. T Bloomgarden Developments in Diabetes and Insulin Resistance Diabetes Care, January 1, 2006; 29(1): 161 - 167. [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, September 1, 2005; 28(9): 2289 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Reaven Counterpoint: Just Being Alive Is Not Good Enough Clin. Chem., August 1, 2005; 51(8): 1354 - 1357. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. VanVoorhis, and D. H. Jagasia Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome Obstet. Gynecol., July 1, 2005; 106(1): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Sumner, K. B. Finley, D. J. Genovese, M. H. Criqui, and R. C. Boston Fasting Triglyceride and the Triglyceride-HDL Cholesterol Ratio Are Not Markers of Insulin Resistance in African Americans Arch Intern Med, June 27, 2005; 165(12): 1395 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wahrenberg, K. Hertel, B.-M. Leijonhufvud, L.-G. Persson, E. Toft, and P. Arner Use of waist circumference to predict insulin resistance: retrospective study BMJ, June 11, 2005; 330(7504): 1363 - 1364. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven Dr. Reaven responds: Clin. Chem., June 1, 2005; 51(6): 1083 - 1084. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven The Metabolic Syndrome: Requiescat in Pace Clin. Chem., June 1, 2005; 51(6): 931 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A Enas, A. Senthilkumar, C. Vinod, and N. Puthumana Dyslipidaemia among Indo-Asians strategies for identification and management The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2): 81 - 90. [Abstract] [PDF]
|
|
|
|
 |
|
 S. E. Stern, K. Williams, E. Ferrannini, R. A. DeFronzo, C. Bogardus, and M. P. Stern Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements Diabetes, February 1, 2005; 54(2): 333 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity Clin. Chem., December 1, 2004; 50(12): 2316 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs Metabolic Syndrome: In search of a clinical role Diabetes Care, November 1, 2004; 27(11): 2761 - 2763. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rizvi Metabolic Markers of Insulin Resistance in Overweight Persons Ann Intern Med, August 3, 2004; 141(3): 243 - 243. [Full Text] [PDF]
|
|
|
|
|
|
U. Riserus, J. Arnlov, K. Brismar, B. Zethelius, L. Berglund, and B. Vessby Sagittal Abdominal Diameter Is a Strong Anthropometric Marker of Insulin Resistance and Hyperproinsulinemia in Obese Men Diabetes Care, August 1, 2004; 27(8): 2041 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Carr, K. M. Utzschneider, R. L. Hull, K. Kodama, B. M. Retzlaff, J. D. Brunzell, J. B. Shofer, B. E. Fish, R. H. Knopp, and S. E. Kahn Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome Diabetes, August 1, 2004; 53(8): 2087 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vinicor and B. Bowman The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes: Response to Davidson and Alexander Diabetes Care, May 1, 2004; 27(5): 1243 - 1243. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Shishehbor, B. J. Hoogwerf, and M. S. Lauer Association of Triglyceride-to-HDL Cholesterol Ratio With Heart Rate Recovery Diabetes Care, April 1, 2004; 27(4): 936 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven Insulin Resistance, Cardiovascular Disease, and the Metabolic Syndrome: How well do the emperor's clothes fit? Diabetes Care, April 1, 2004; 27(4): 1011 - 1012. [Full Text] [PDF]
|
|
|
|
|
|
I. Malik JournalScan Heart, February 1, 2004; 90(2): 235 - 236. [Full Text] [PDF]
|
|
Article
